Breast cancer
Results
Phase 2
This trial looked at palbociclib and letrozole for women before surgery to remove their breast cancer.
It was for women:
whose breast cancer hadn’t spread elsewhere in the body
who had gone through the menopause
whose breast cancer had receptors for the hormone oestrogen (oestrogen receptor positive or ER positive)
Cancer Research UK supported this trial.
This trial was open for people to join between 2015 and 2018. The team published the results in 2018.
Recruitment start: 27 February 2015
Recruitment end: 8 March 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stephen Johnson
Cancer Research UK
Institute of Cancer Research (ICR)
The Royal Marsden NHS Foundation Trust
Pfizer
NSABP, USA
International Drug Development Institute (IDDI), USA
This is Cancer Research UK trial number CRUK/13/031.
Last reviewed: 2 September 2020
CRUK internal database number: 11761
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
